Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21Neoplasms 3Urogenital Neoplasms 1Prostatic Diseases 1Prostate Cancer Metastatic 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Metastatic Castrate-resistant Prostate Cancer 1Hormone-Refractory Prostate Cancer 1Genital Neoplasms, Male 1Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1Carcinoma 1Adenocarcinoma of the Prostate 1Adenocarcinoma 1

Interventions

padeliporfin 4sipuleucel-T 1niraparib 1luprolide acetate gel depot 1apalutamide 1Therapeutics 1Tamsulosin 1Surveys and Questionnaires 1Prostate-Specific Antigen 1Paclitaxel 1Oxygen 1Nitrous Oxide 1Microtubule-Associated Proteins 1Leuprolide 1Imatinib Mesylate 1Cryotherapy 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Diseases × sipuleucel-T × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡